WESTPORT, Conn.--(BUSINESS WIRE)--Advanced BioHealing, Inc. (ABH), a leader in commercializing the promise of regenerative medicine, announced that the Centers for Medicare and Medicaid Services (CMS) has proposed to create a new G-code for the application of Dermagraft® with a 0-day global period for calendar year 2011. This proposal was included in the Medicare Physician Fee Schedule Proposed Rule released on Friday, June 25, 2010.
